Central Precocious Puberty in a 9-Month-Old Infant Due to Hypothalamic Hamartoma: A Case Report
Abstract
Central precocious puberty is a rare endocrine disorder characterised by premature activation of the hypothalamic–pituitary–gonadal (HPG) axis, leading to the onset of pubertal development before the defined age criteria. This condition is predominantly seen in girls and is usually sporadic in nature. We report an unusual case of central precocious puberty (CPP) in a 9-month-old female infant who presented with regular
menstrual cycles from 5 months of age. The infant was assessed clinically on an outpatient basis and subsequently investigated with neuroimaging and hormonal studies. She was diagnosed with a hypothalamic hamartoma as the underlying cause of CPP and was successfully initiated on a GnRH analogue (leuprolide depot), with subsequent regression of pubertal signs and cessation of menses.
[2] Rohayem J, Alexander EC, Heger S, Nordenström A, Howard SR. Mini-puberty, physiological and disordered: consequences, and potential for therapeutic replacement. Endocr Rev. 2024;45(4):460-92. https://doi.org/10.1210/endrev/bnae003
[3] Bräuner EV, Busch AS, Eckert-Lind C, Koch T, Hickey M, Juul A. Trends in the incidence of central precocious puberty and normal variant puberty among children in Denmark, 1998 to 2017. JAMA Netw Open. 2020;3(10):e2015665. https://doi.org/10.1001/jamanetworkopen.2020.15665
[4] Kim YJ, Kwon A, Jung MK, Kim KE, Suh J, Chae HW, et al. Incidence and prevalence of central precocious puberty in Korea: an epidemiologic study based on a national database. J Pediatr. 2019;208:221-8. https://doi.org/10.1016/j.jpeds.2018.12.022
[5] Cisternino M, Arrigo T, Pasquino AM, et al. Etiology and age incidence of precocious puberty in girls: a multicentric study. J Pediatr Endocrinol Metab. 2000;13 Suppl 1:695-701. https://doi.org/10.1515/JPEM.2000.13.S1.695
[6] Carel JC, Léger J. Clinical practice. Precocious puberty. N Engl J Med. 2008;358(22):2366-77. https://doi.org/10.1056/
NEJMcp0800459
[7] Vuralli D, Gonc EN, Alikasifoglu A, Kandemir N, Ozon ZA. Central nervous system imaging in girls with central precocious puberty: when is it necessary? Arch Endocrinol Metab. 2021;64(5):591- 6. https://doi.org/10.20945/2359-3997000000259
[8] Lee J, Kim J, Yang A, Cho SY, Jin DK. Etiological trends in male central precocious puberty. Ann Pediatr Endocrinol Metab. 2018;23(2):75-80. https://doi.org/10.6065/apem.2018.23.2.75
[9] Suh J, Choi Y, Oh JS, Song K, Choi HS, Kwon A, et al. Management of central precocious puberty in children with
hypothalamic hamartoma. Children (Basel). 2021;8(8):711. https://doi.org/10.3390/children8080711
[10] Agrawal M, Samala R, Doddamani RS, Goyal A, Tripathi M, Chandra PS. Is surgery effective for treating hypothalamic hamartoma causing isolated central precocious puberty? A systematic review. Neurosurg Rev. 2021;44(6):3087-105. https://doi.org/10.1007/s10143-021-01512-6
[11] Mitrica M, Manole AM, Toma M, Sirbu OM, Sirbu AM, Munteanu AE. Hypothalamic hamartomas: a narrative review.
Biomedicines. 2025;13(2):371. https://doi.org/10.3390/biomedicines13020371
[12] Abel TJ, Woodroffe RW, Couture DE, Kawasaki H. Advances in the neurosurgical management of epilepsy caused by hypothalamic hamartoma. J Pediatr Epilepsy. 2014;3(1):45-53. https://doi.org/10.3233/PEP-14075
| Files | ||
| Issue | Vol 11 No 4 (2026): July-August | |
| Section | Case Report(s) | |
| Keywords | ||
| Central precocious puberty Hypothalamic hamartoma GnRH therapy Hypothalamic– pituitary–gonadal axis Kisspeptin | ||
| Rights and permissions | |
|
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |

